1. Home
  2. OIS vs OCGN Comparison

OIS vs OCGN Comparison

Compare OIS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil States International Inc.

OIS

Oil States International Inc.

N/A

Current Price

$8.56

Market Cap

552.6M

Sector

Industrials

ML Signal

N/A

Logo Ocugen Inc.

OCGN

Ocugen Inc.

N/A

Current Price

$0.98

Market Cap

474.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OIS
OCGN
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.6M
474.8M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
OIS
OCGN
Price
$8.56
$0.98
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$14.00
$9.75
AVG Volume (30 Days)
447.0K
6.7M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$1,088,133,000.00
N/A
Revenue This Year
$3.12
N/A
Revenue Next Year
$5.89
$1,718.38
P/E Ratio
$71.67
N/A
Revenue Growth
62.26
N/A
52 Week Low
$5.50
$1.01
52 Week High
$14.50
$2.73

Technical Indicators

Market Signals
Indicator
OIS
OCGN
Relative Strength Index (RSI) 49.37 29.46
Support Level $7.97 N/A
Resistance Level $8.93 $1.93
Average True Range (ATR) 0.31 0.07
MACD -0.03 -0.04
Stochastic Oscillator 52.48 4.55

Price Performance

Historical Comparison
OIS
OCGN

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: